Sponsored by

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1026 to 1050 of about 5880

Previous 25

Website Changes

07/29/2019

Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.

07/29/2019

Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study.

07/29/2019

Valerie Harper to stay out of hospice care, husband says

07/26/2019

Musella Foundation Brain Tumor Copay Program has reopened!

07/20/2019

A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma

07/19/2019

Study hints at why an aggressive form of brain cancer is hard to treat

07/19/2019

A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma)

07/18/2019

Medicare Releases Final Local Coverage Determination Providing Coverage of Optune® for Newly Diagnosed Glioblastoma

07/17/2019

ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology Company

07/17/2019

Electricity helps control man’s brain tumor

07/16/2019

GBM Awareness Day This Wednesday July 17th!

07/16/2019

Neoadjuvant Anti-PD-1 Immunotherapy Leads to Survival Benefit in Recurrent Glioblastoma

07/16/2019

Attend an Optune Open House.

07/15/2019

Phase II study of Dovitinib in recurrent glioblastoma.

07/06/2019

Insurance type impacts the economic burden and survival of patients with newly diagnosed glioblastoma.

07/01/2019

Defeat DIPG Executive Director Jenny Mosier Speaks at FDA Public Hearing Regarding ONC201

06/25/2019

Integrating Clinical Research And Care In A Perpetual Trial

06/24/2019

Musella Foundation awards 9 grants!

06/22/2019

Medicenna Presents Preliminary Top-Line Clinical Results from their Phase 2b Trial of MDNA55 in Recurrent Glioblastoma

06/22/2019

New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors

06/22/2019

Bayer’s regorafenib kicks off brain cancer platform trial

06/13/2019

Webinar: Personalized Approaches to Treating Cancer Explained in Plain Language

06/12/2019

Glioblastoma Awareness Day Resolution Passes U.S. Senate with Unanimous Support

06/11/2019

Oncology Expert Keith T. Flaherty, MD Named Chairman of xCures Scientific Advisory Board

06/10/2019

Attend an Optune Open House.

Our privacy / cookie policy has changed.
Click HERE to read it!